Skip to content

Mescaline research published in 2025

24 studies whose primary subject is mescaline were published in 2025, the same as in 2024. Newest first. Back to the mescaline overview

Studies

Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase)

Psychiatry Research December 29, 2025 Omer A. Syed, Sean M. Nestor, Muhammad Ishrat Husain et al. 1 citation

Psychedelic use has greatly increased within clinical and recreational settings over recent years. While demonstrating a favorable safety profile within certain clinical populations, little empirical research has explored safety of psychedelic use within real-world samples. Using the World Health Organization (WHO) VigiBase, a comprehensive global pharmacovigilance database with voluntary...

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.

Journal of Psychopharmacology December 26, 2025 Kurt Stocker, Matthias Hartmann, Yasmin Schmid et al. 5 citations

The Altered States of Consciousness Scale (3/5D-ASC or 11-ASC) is widely used to assess non-ordinary states of consciousness, particularly for psychedelic research. However, its original dimensional model (3D-ASC within 5D-ASC) and later 11-subscale structure (11-ASC) have a hierarchically incompatible higher/lower-order structure. Although the 11-ASC offers superior model fit, the 3D-ASC...

The first applications of mescaline in psychiatry: The case of Madame Louise Françoise R. and its contemporary relevance

Neuropharmacology October 15, 2025 Marion Hendrickx, Antoine Dampierre, Emmanuel Drouin 1 citation

At the beginning of the 20th century, while psychiatric knowledge remained limited, some physicians were already exploring innovative experimental paths. This article presents an unpublished clinical case of a patient, Madame Louise Françoise R., treated with mescaline in 1930 by Henri Claude and Henri Ey at Sainte-Anne in Paris, four years before their official publication on the subject. The...

DOI: 10.1016/j.neuropharm.2025.110707 (opens in new tab) Mescaline Ambivalence Perspective graphical Relevance law +5

Gheorghe Marinescu's studies on the influence of mescaline on artistic creativity.

Medicine and Pharmacy Reports October 1, 2025 Irina Dora Magurean, Vlaicu Sandor, Dan L Dumitrascu

The artists of the avant-garde experienced numerous psychotropic drugs in order to stimulate their creativity. Between the two world wars, physicians, especially neurologists and psychiatrists, performed several studies on visual artists. The aim of this paper is to present a French medical journal, where the famous Romanian neurologist Gheorghe Marinescu published some of his studies on the...

DOI: 10.15386/mpr-2901 (opens in new tab) Full text (opens in new tab) Mescaline Gheorghe marinescu History of medicine Narcotics +1

Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review

Brazilian Journal of Science September 29, 2025 Pinelopi Vlotinou, Konstantinos Christodoulou, Anna Tsiakiri et al.

Classical psychedelics encompass psilocybin, lysergic acid diethylamide (LSD), N, N-dimethyltryptamine (DMT), and mescaline and are psychoactive substances that primarily function as agonists at the serotonin 5-hydroxytryptamine receptors (5-HT). In the immediate term, they modify perception, cognition, emotional state, social processing, and introspection, leading to a subjective mystical...

Freedom of Recreation: A Critique of the Prohibition, Decriminalization, and Legal Regulation of Psychedelics for Recreational Use

Contemporary Drug Problems August 28, 2025 Jason K. Day, Michael Th. Grooff 1 citation

Established by the 1971 United Nations (UN) Convention on Psychotropic Substances, the prohibition of the recreational use of psychedelics (lysergic acid diethylamide [LSD], psilocybin, N , N -dimethyltryptamine [ N , N -DMT], and mescaline) has two premises. First, recreational use poses a serious threat to public health because psychedelics are highly liable to addiction and abuse. Second,...

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.

Clinical Pharmacokinetics July 14, 2025 Lorenz Mueller, Aaron Klaiber, Laura Ley et al. 4 citations

Mescaline is a classic serotonergic psychedelic with a long history of human use. The present study analyzed the pharmacokinetics, pharmacokinetic-pharmacodynamic relationship, and urinary recovery of oral mescaline hydrochloride. Data from 105 single-dose administrations (100-800 mg) in 49 participants from two phase I trials were analyzed with compartmental pharmacokinetics and...

A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction

Journal of Psychopharmacology July 11, 2025 Diana Glenn, Seung Hee Choi, Rick S. Zimmerman 1 citation

Background: Classic serotonergic psychedelics are 5-HT2A partial agonists that induce non-ordinary states of consciousness. Many have demonstrated anti-addictive properties; however, their impact on smoking behaviors remains under-researched. This review provides a synthesis of the therapeutic potential of these compounds in promoting smoking cessation and reduction. Methods: A systematic...

Serotonin 2C receptors are also important in head-twitch responses in male mice.

Psychopharmacology July 1, 2025 Raly James Perez Custodio, Darlene Mae Ortiz, Hyun Jun Lee et al. 8 citations

Serotonergic psychedelics exert their effects via their high affinity for serotonin (5-HT) receptors, particularly through activating 5-HT2A receptors (5-HT2AR), employing the frontal cortex-dependent head-twitch response (HTR). Although universally believed to be so, studies have not yet fully ascertained whether 5-HT2AR activation is the sole initiator of these psychedelic effects. This is...

The San Pedro Cactus (Equinopsis pachanoi): Ancestral and Modern Therapeutic Uses in Peru

June 16, 2025 Fanny Charrasse, Alfredo Narváez 1 citation

We describe the curanderos of the Túcume district, a land of farmers and territory of the Pyramids of Túcume, one of the most important archaeological monuments on the north coast of Peru. The use of the San Pedro cactus (Equinopsis species) as an entheogenic agent is guided by a specialist, a curandero or “master healer”, who directs a complex ritual around a healing “altar”. This “altar” is...

Pathway engineering for the biosynthesis of psychedelics

Current Opinion in Biotechnology May 15, 2025 Zachary N. Abrahms, Abhishek K. Sen, J. Andrew Jones 2 citations

Naturally occurring psychoactive compounds have been used for cultural and ethnomedical purposes for centuries. Several more such molecules continue to be chemically synthesized, exhibiting a wide range of potency, therapeutic, and hallucinogenic effects. Promising clinical data and a renewed interest in understanding the cellular mechanisms of action have inspired synthetic biology efforts to...

Utilizing Psychedelics to Enhance Well-Being: A Systematic Review

Journal of Psychoactive Drugs March 31, 2025 Samuel Thomson, Nikos Thomacos 11 citations

Psychedelic-assisted therapy is gaining recognition for its potential to enhance human functioning. While most research has focused on psychedelic' therapeutic use for mental illness, this review applies the PERMA Theory of Well-Being to systematically examine their role in enhancing well-being in healthy individuals. The final search of five academic databases was conducted on February 4,...

Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.

Psychopharmacology March 26, 2025 Laura Ley, Matthias E. Liechti, Anna M Becker et al. 3 citations

Little is known about motives of healthy volunteers to participate in psychedelic trials and how they appraise their study experience retrospectively. This paper explored reasons why healthy people register for psychedelic trials, factors that they considered to contribute to either positive or negative study experiences, and under which circumstances they would seek a psychedelic experience...

A UHPLC-(ESI)MS/MS method for the determination of the psychedelic secondary metabolite mescaline in San Pedro (Trichocereus spp.) and its applicability for screening mescaline in other cacti varieties.

Forensic Chemistry March 25, 2025 Pragna Gaur, Liam Engel, Damian Robert Hall et al. 1 citation

Commencements of clinical trials of psychedelic therapies for intractable forms of mental illnesses have drawn increased public attention to plants containing psychedelic substances. Whilst the psychoactive alkaloid mescaline has limited clinical trials, the San Pedro ( Trichocereus spp.) cacti from which it is found have a long history of Indigenous medical and spiritual use. Traditional use...

DOI: 10.1016/j.forc.2025.100659 (opens in new tab) Mescaline Secondary metabolite Chromatography Traditional medicine +2

PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS

Journal of medical & health sciences review. March 11, 2025 Ahmad Daryani, Muhammad Ali, Usman Ul Haq

Psilocybin, MDMA, and LSD have recently emerged as popular psychedelic substances for use in psychopharmacology in managing various disorders including treatment-resistant depression, PTSD, and anxiety. These substances mainly affect the serotonergic receptors that involve the regulation of consciousness, perceptions, and cognition. These unique alterations in brain connectome show the...

Comparative transcriptomic analysis provides novel insights into mescaline biosynthesis by Lophophora williamsii.

Journal of Forensic Sciences March 1, 2025 Eun-Mi Hwang, Kyu-Sik Jeong, Seong Yeon Yoo et al.

Lophophora williamsii, known for mescaline synthesis, has raised legal and ethical considerations. However, L. williamsii specimens that do not contain mescaline have been recently identified, necessitating the development of techniques to differentiate between mescaline-positive and mescaline-negative groups. Genetic markers have been explored to differentiate these specimens, complementing...

“Plants Don’t Have a Culture to Appropriate”: Accounting for Accusations of Cultural Appropriation of Peyote Ceremonies

Sociology Compass February 26, 2025 Heith Copes, Haley Copeland, Lynne M. Vieraitis et al.

ABSTRACT The concept of cultural appropriation has drawn increasing attention from academic disciplines and nonacademic circles. Yet, there is no consensus on what constitutes cultural appropriation nor whether it is harmful. The contested nature of the concept suggests that it is important to understand how people respond to such accusations. Indeed, understanding how people resist accusations...

DOI: 10.1111/soc4.70048 (opens in new tab) Cultural appropriation Anthropology Epistemology

The Trouble With Psychedelic Cacti: Conflicting Meanings of San Pedro and Peyote

Contemporary Drug Problems February 10, 2025 Liam Engel, Mitchell Low 1 citation

Using autoethnography, this article considers conflict surrounding the psychedelic, mescaline cacti, San Pedro, and Peyote. We reflect on themes emergent in the lead authors’ lived experiences with growing, researching and working with mescaline cacti; Indigenous culture, psychopharmacotherapy research, psychedelic markets and ecology. These themes are considered relative to varied San Pedro...

Application of microarray patches for the transdermal administration of psychedelic drugs in micro-doses.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V February 1, 2025 Octavio E Fandiño, Aaron R J Hutton, Chunyang Zhang et al. 4 citations

Throughout history, psychedelic compounds have been used for religious, spiritual and recreational purposes. A plethora of studies have reported the use of psychedelic compounds in the treatment of various conditions, such as alcoholism, addictions, depressive state to borderline schizophrenia, personality disorder, among other mental disorders. Psychedelic microdosing, a common technique in...

Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.

Expert Review of Neurotherapeutics February 1, 2025 Donatella Marazziti, Francesco Weiss, Riccardo Gurrieri et al. 4 citations

After a long period of obscurantism, a possible role of psychedelics in clinical practice has progressively become a tangible perspective during the last two decades. However, the resounding enthusiasm linked to such 'psychedelic renaissance' runs the risk to unduly minimize the possible hazards associated with these compounds, while expanding their alleged benefits to improbable panacea-like...